Live Breaking News & Updates on Anne Elmer

Stay updated with breaking news from Anne elmer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Pfizer-BioNTech COVID-19 vaccine immune response in the elderly


Pfizer-BioNTech COVID-19 vaccine immune response in the elderly
In the absence of therapeutic intervention, vaccines are the only available avenue to contain the COVID-19 (coronavirus disease 2019) pandemic. Currently, vaccines against the causal agent, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), are being administered globally.
It is essential to understand the vaccine response to know its efficacy under diverse plans and cohorts. The duration of protection imparted by the current vaccine is unknown in a real-world setting. This is important, particularly in underrepresented groups in clinical trials. One such group is the elderly population, aged above 80 years, who are at the most significant risk of death from COVID-19 disease. ....

United Kingdom , Anne Elmer , Paul Lyons , John Bradley , Ravindrak Gupta , Gabriela Barcenas Morales , Ramya Dwivedi , Rawlings Datir , Laura Bergamaschi , Isabella Ferreira , Lourdes Ceron Gutierrez , Rainer Doffinger , Mark Wills , Bo Meng , Professor Ravindra , Igg Spike , Dami Collier , Nathalie Kingston , Barbara Graves , Immune Response , Corona Virus , Coronavirus Disease Covid 19 , Sars Cov 2 , Severe Acute Respiratory , Severe Acute Respiratory Syndrome , ஒன்றுபட்டது கிஂக்டம் ,